PMP Hollow Fiber Membrane for ECMO Market Summary
The PMP (Poly – 4 – methyl – 1 – pentene) hollow fiber membrane for ECMO (Extracorporeal Membrane Oxygenation) is a key material specifically used in the ECMO equipment. It is a film with a hollow – fiber – like structure made of Poly – 4 – methyl – 1 – pentene. This film enables efficient and selective exchange between blood and gases (oxygen and carbon dioxide) and is one of the core components for the ECMO system to provide life – support to patients.
According to the new market research report “Global PMP Hollow Fiber Membrane for ECMO Market Report 2026-2032”, published by QYResearch, the global PMP Hollow Fiber Membrane for ECMO market size is projected to reach USD 52 million by 2032, at a CAGR of 5.6% during the forecast period.
Figure00001. Global PMP Hollow Fiber Membrane for ECMO Market Size (US$ Million), 2021-2032
Above data is based on report from QYResearch: Global PMP Hollow Fiber Membrane for ECMO Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.
1. Market Drivers
Driver 1: Rising ECMO Utilization and Installed Base Expansion
The first structural driver is the continued expansion of ECMO use in critical care. ELSO’s international report covering data through 2024 shows 245,291 cumulative ECMO runs, 596 reporting centers in 2024, and 21,118 runs in 2024 alone. This growing installed base increases recurring demand for oxygenators and, upstream, for high-performance hollow fiber membrane materials. For PMP membrane suppliers, the market is not driven only by new device launches, but also by broader center participation, higher case volumes, and more standardized ECMO adoption in adult, pediatric, and neonatal care. That creates a durable demand foundation for qualified membrane materials with proven long-duration performance.
Driver 2: Clinical Preference for Longer-Duration Oxygenation Materials
A second driver is the clinical shift from short-term oxygenation toward membranes that can support longer extracorporeal runs with better safety margins. Solventum states that OXYPLUS capillary membranes are suitable for longer-term use and approved in applications for up to two weeks, while Cobetter positions its PMP capillary membrane for extracorporeal life support applications of over 24 hours, versus PP membranes mainly for applications of less than 6 hours. This reinforces PMP’s value proposition in modern ECMO: higher gas transfer stability, better plasma leakage resistance, and stronger fit for extended support scenarios than conventional porous PP routes.
Driver 3: Need for Better Plasma-Leakage Resistance and Hemocompatibility
A third driver is performance upgrading at the membrane-material level. Recent reviews note that hollow-fiber PMP oxygenators have become a key practical advance because their asymmetric structure with a dense outer layer greatly reduces the plasma leakage problem associated with older membrane systems. At the same time, the literature still emphasizes that ECMO membranes must balance gas permeability, blood compatibility, thrombosis control, and mechanical durability. This means OEMs continue to favor PMP platforms that offer not just oxygen transfer, but also longer operating windows and lower clinical risk. In other words, performance requirements are pushing the market toward premium-grade PMP membranes rather than commoditized alternatives.
2. Market Restraints
Restraint 1: Highly Concentrated Upstream PMP Resin Supply
The most important restraint is upstream raw-material concentration. Publicly available industry material from Mitsui Chemicals identifies TPX™ as polymethylpentene, and Mitsui’s own product communication states that TPX-based PMP resin is produced solely by Mitsui Chemicals. In practical terms, this means ECMO PMP membrane makers face a strategically concentrated resin supply base, which can limit bargaining flexibility, increase qualification dependence, and raise continuity risk during demand shocks. Even if membrane producers can optimize formulations and processes internally, they still depend on a narrow upstream source for the core polymer. That concentration materially constrains industry expansion and increases supply-chain sensitivity.
Restraint 2: High Process Complexity and Qualification Barriers
ECMO-grade PMP membrane production is not a simple melt-processing business. Manufacturers must tightly control TIPS or hybrid TIPS/NIPS processing, including dope formulation, extrusion temperature, air-gap residence time, quench conditions, extraction, and drying, to achieve the desired asymmetric structure and dense skin. At the commercial level, Solventum also stresses scale-up efficiency and compliance with stringent regulatory standards for medical device manufacturing. This means a new entrant must master both membrane science and highly disciplined medical-device quality systems. The result is a long development cycle, high capex burden, and a demanding validation pathway before commercial acceptance.
Restraint 3: Persistent Blood-Contacting Material Challenges
Although PMP is a leading material, it does not eliminate all clinical-material risks. Reviews still highlight protein deposition, thrombosis, hemolysis, and blood-material interaction as major issues in ECMO practice, and even PMP oxygenators have had reported cases of plasma leakage under certain conditions. This matters commercially because membrane suppliers are judged not only on gas transfer, but also on anticoagulation burden, clotting behavior, and long-run stability inside the oxygenator. As a result, clinical complications remain a restraint on adoption speed, increase R&D costs for surface treatment and coating technologies, and raise the evidentiary burden for newer suppliers trying to displace established materials.
Figure00002. Global PMP Hollow Fiber Membrane for ECMO Top 2 Players Ranking and Market Share (Ranking is based on the revenue of 2025, by revenue, continually updated)
Above data is based on report from QYResearch: Global PMP Hollow Fiber Membrane for ECMO Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.
According to QYResearch Top Players Research Center, the global key manufacturers of PMP Hollow Fiber Membrane for ECMO include Solventum, Hangzhou Cobetter. In 2025, the global top two players had a share approximately 100.0% in terms of revenue.
Hangzhou Cobetter Filtration Equipment Co., Ltd. is a world-class leader in microporous filtration technology and one of the largest filtration, separation, and purification solution providers in Asia. Specializing in the research and manufacturing of advanced membrane materials, Cobetter has successfully developed a full spectrum of core membranes, including PES, PTFE, Nylon, and PVDF. This technical depth allows the company to provide high-performance alternatives to traditional Western-dominated brands in high-stakes industries.
The company serves a diverse range of sectors, with a particularly strong presence in the semiconductor, biopharmaceutical, and medical device markets. In the semiconductor industry, Cobetter offers specialized filtration systems for photoresists, wet chemicals, and ultra-pure water, meeting the stringent purity requirements of modern wafer fabrication. In life sciences, its products comply with rigorous international regulatory standards for sterile filtration and virus removal. Headquartered in Hangzhou, China, Cobetter operates state-of-the-art manufacturing facilities with ISO-certified cleanrooms and a comprehensive validation center to ensure product integrity. Through a growing network of international subsidiaries and technical support centers, Cobetter continues to expand its global footprint, delivering innovative, cost-effective, and reliable fluid purification solutions to a worldwide clientele.
Figure00003. PMP Hollow Fiber Membrane for ECMO, Global Market Size, Split by Product Segment
Based on or includes research from QYResearch: Global PMP Hollow Fiber Membrane for ECMO Market Report 2026-2032.
About The Authors
| Zhang Xuelu – Analyst for this report | |
| Email: zhangxuelu@qyresearch.com
|
|
| Website: www.qyresearch.com Hot Line:4006068865
QYResearch focus on Market Survey and Research US: +1-888-365-4458(US) +1-202-499-1434(Int’L) EU: +44-808-111-0143(UK) +44-203-734-8135(EU) Asia: +86-10-8294-5717(CN) +852-30628839(HK) |
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
